Inhibition of c-Jun N-terminal kinase signaling increased apoptosis and prevented the emergence of ALK-TKI-tolerant cells in ALK-rearranged non-small cell lung cancer
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 522, 119-128
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Intra-tumour heterogeneity: a looking glass for cancer?Nature Reviews Cancer, 2012
- The JNK inhibitor SP600125 enhances dihydroartemisinin‐induced apoptosis by accelerating Bax translocation into mitochondria in human lung adenocarcinoma cellsFEBS Letters, 2010
- Growth Factor Stimulation Induces Cell Survival by c-Jun·ATF2-dependent Activation of Bcl-XLJournal of Biological Chemistry, 2010
- JNK inhibitor SP600125 promotes the formation of polymerized tubulin, leading to G2/M phase arrest, endoreduplication, and delayed apoptosisExperimental & Molecular Medicine, 2009
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerNature, 2007
- JNK- and p38 Kinase-mediated Phosphorylation of Bax Leads to Its Activation and Mitochondrial Translocation and to Apoptosis of Human Hepatoma HepG2 CellsJournal of Biological Chemistry, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosisProceedings of the National Academy of Sciences, 2003
- JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domainCell, 1994
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984